![]() | Only 14 pages are availabe for public view |
Abstract Acute cornary syndrome represents the acute life threatening phase of coronary heart disease as acute myocardial infarction or its complications cause one every five deaths nationwide. Cardiac Troponin elevation reflects myocardial cellular damage. Patients with elevated Troponin have an unfavourable short and long – term clinical outcome when compared to those without troponin elevation. Patients with elevated troponin benefit from treatment with low-molecular weight heparin or GPIIb/IIIa blockers , while no such benefit was observed in patients without troponin elevation. Troponin I is the most sensetive and diagnostic cardiac marker that assists in patient management strategies and it can predict the success or failure of reperfusion. This study was conducted on 62 patients with acute coronary syndrome underwent PCI & they were divided into 3 groups according to the troponin I level in their venous blood post PCI. |